TrialJournal of pharmacokinetics and pharmacodynamics2012

From in vitro EC₅₀ to in vivo dose-response for antiretrovirals using an HIV disease model. Part I: a framework.

Jing Fang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.